Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Diffuse Large B-Cell Lymphoma

Known as: large cell diffuse lymphoma, DLBCL, Lymphoma, Diffuse Large Cell 
A non-Hodgkin lymphoma characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes. It is the most frequently seen type… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Immunotherapy has become an established pillar of cancer treatment improving the prognosis of many patients with a broad variety… Expand
  • figure 1
  • figure 2
Review
2019
Review
2019
Adoptive cellular immunotherapy with chimeric antigen receptor (CAR) T cell has changed the treatment landscape of B-cell non… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Review
2019
Review
2019
Chimeric antigen receptor (CAR) T‐cell therapy represents a major advancement in personalized cancer treatment. In this strategy… Expand
Review
2019
Review
2019
Chimeric antigen receptor (CAR) T-cell therapy is an effective new treatment for hematologic malignancies. Two CAR T-cell… Expand
Review
2019
Review
2019
Summary Background Biologically distinct subtypes of diffuse large B-cell lymphoma can be identified using gene-expression… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Review
2019
Review
2019
BACKGROUND Patients with diffuse large B‐cell lymphoma that is refractory to primary and second‐line therapies or that has… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
Review
2019
Review
2019
Abstract Background Patients with diffuse large B-cell lymphoma that is refractory to primary and second-line therapies or that… Expand
Review
2019
Review
2019
We present RAPID (Real-time Automated Photometric IDentification), a novel time-series classification tool capable of… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Review
2018
Review
2018
Human T-cell leukemia virus type 1 (HTLV-1) is the causative agent of a fatal malignancy known as adult T-cell leukemia (ATL… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Review
2018
Review
2018
Purpose of ReviewGenetically engineered T cells expressing a chimeric antigen receptor (CAR-T) targeting specific antigens… Expand
  • table 1